ATE340504T1 - Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen - Google Patents

Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen

Info

Publication number
ATE340504T1
ATE340504T1 AT00907842T AT00907842T ATE340504T1 AT E340504 T1 ATE340504 T1 AT E340504T1 AT 00907842 T AT00907842 T AT 00907842T AT 00907842 T AT00907842 T AT 00907842T AT E340504 T1 ATE340504 T1 AT E340504T1
Authority
AT
Austria
Prior art keywords
transplantation
organ
solutions
soluble
membrane
Prior art date
Application number
AT00907842T
Other languages
English (en)
Inventor
Richard Anthony Godwin Smith
Julian Roy Pratt
Steven Howard Sacks
Original Assignee
Adprotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech Ltd filed Critical Adprotech Ltd
Application granted granted Critical
Publication of ATE340504T1 publication Critical patent/ATE340504T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00907842T 1999-03-10 2000-03-08 Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen ATE340504T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9905503.0A GB9905503D0 (en) 1999-03-10 1999-03-10 Novel compound formulations and methods of delivery

Publications (1)

Publication Number Publication Date
ATE340504T1 true ATE340504T1 (de) 2006-10-15

Family

ID=10849347

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907842T ATE340504T1 (de) 1999-03-10 2000-03-08 Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen

Country Status (10)

Country Link
US (1) US7888318B1 (de)
EP (1) EP1158854B1 (de)
JP (1) JP4873784B2 (de)
AT (1) ATE340504T1 (de)
AU (1) AU773516B2 (de)
CA (1) CA2367073A1 (de)
DE (1) DE60030960T2 (de)
ES (1) ES2273668T3 (de)
GB (1) GB9905503D0 (de)
WO (1) WO2000053007A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3479838A1 (de) * 2003-02-04 2019-05-08 Cornell Research Foundation, Inc. Verwendung von aromatisch kationischem peptid
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
ES2330404B1 (es) * 2008-05-19 2010-09-22 Universidad De Barcelona Solucion acuosa para la preservacion de tejidos y organos.
US20120148542A1 (en) * 2010-12-10 2012-06-14 Lifeline Scientific, Inc. Machine perfusion with complement inhibitors
US11127306B2 (en) 2017-08-21 2021-09-21 Precisionos Technology Inc. Medical virtual reality surgical system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
IL89790A (en) 1988-04-01 2002-05-23 Johns Hopking University Nucleic acid sequences that encode and cells that produce cr1 protein and methods of production and purification
WO1990010385A1 (en) 1989-03-15 1990-09-20 Tykocinski Mark L Cd8-based pharmaceuticals
RO109863B1 (ro) 1989-10-12 1995-06-30 Imutran Ltd Gena care codifica cel putin un factor de restrictie complementar, animal transgenic si metode de transplantare a tesuturilor sau organelor animale
JP3939747B2 (ja) 1992-06-24 2007-07-04 アドプロテック・リミテッド 可溶性ｃｒ１誘導体
AU6409594A (en) * 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Preservation solution and method for warm organ preservation
ES2174876T3 (es) * 1993-05-17 2002-11-16 Avant Immunotherapeutics Inc Composiciones que comprenden proteinas relacionadas con el complementoy carbohidratos y metodos para producir y usar dichas composiciones.
ES2204944T3 (es) 1994-03-03 2004-05-01 Alexion Pharmaceuticals, Inc. Genes y proteinas de fusion inhibidores del complemento terminal.
US5554497A (en) 1994-12-12 1996-09-10 Charlotte-Mecklenburg Hospital Authority Cardioplegic solution for arresting an organ
WO1997011601A1 (en) * 1995-09-28 1997-04-03 The Johns Hopkins University School Of Medicine Method for prevention of xenograft rejection by transplant recipients
GB9523469D0 (en) 1995-11-16 1996-01-17 Sandoz Ltd Organic compounds
WO1997047321A1 (en) 1996-06-14 1997-12-18 The Johns Hopkins University School Of Medicine Use of chimeric vaccinia virus complement control proteins to inhibit complement
GB9614871D0 (en) * 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
GB9704519D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
DE60030960D1 (de) 2006-11-09
JP4873784B2 (ja) 2012-02-08
EP1158854A1 (de) 2001-12-05
ES2273668T3 (es) 2007-05-16
WO2000053007A1 (en) 2000-09-14
EP1158854B1 (de) 2006-09-27
US7888318B1 (en) 2011-02-15
DE60030960T2 (de) 2007-06-14
CA2367073A1 (en) 2000-09-14
AU2930600A (en) 2000-09-28
GB9905503D0 (en) 1999-05-05
JP2002538184A (ja) 2002-11-12
AU773516B2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
AR033834A1 (es) Una proteina de fusion para liberar un compuesto a una celula, un metodo para liberar dicho compuesto, un metodo para identificar un peptido penetrador de membranas, y el uso de una proteina de fusion para la manufactura de un agente
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
Van Deurs et al. Delivery of internalized ricin from endosomes to cisternal Golgi elements is a discontinuous, temperature-sensitive process
NZ333722A (en) Soluble fatty acid derived peptide each with binding element more than 5kD as medicaments for disorders associated with inflammation or inappropriate complement activation
DK0836380T3 (da) FGF9 som en specifik ligand for FGFR3
NO990465L (no) Polypeptider som har en enkel, kovalent bundet N-terminal vannoppl°selig polymer
DE60006100D1 (de) Lang wirkende insulinotrope peptide
BR0116587A (pt) Uso de uma eritropoietina, composição farmacêutica, métodos para proteger, manter ou realçar a viabilidade de uma célula, tecido ou órgão isolado de um corpo mamìfero, para facilitar a trancitose de uma molécula através de uma barreira endotelial celular em um mamìfero, composição para transportar uma molécula via trancitose através de uma barreira endotelial celular, e, composição
DE69840030D1 (de) Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender
DE60034957D1 (de) Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
ATE340504T1 (de) Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen
DK0975334T3 (da) Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler
DK1196196T3 (da) Konjugat til formidling af en celle-, compartment- eller membranspecifik transport af aktivstoffer
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
Liu et al. Activity and in vitro reassembly of the coated vesicle (H+)-ATPase requires the 50-kDa subunit of the clathrin assembly complex AP-2.
Yuan et al. Sublethal heat shock and cyclosporine exposure produce tolerance against subsequent cyclosporine toxicity
DE60125364D1 (de) Auf zelluläre ziele gerichtete verbindungen
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
DE60128218D1 (de) METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR
GB0220936D0 (en) Modified therapeutic agents
DE69900466D1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
NO20021309D0 (no) Preparat for IVF
WO1995006717A3 (en) Methods of suppressing graft rejection
Grant et al. Receptor-mediated endocytosis of enterokinase by rat liver: Preliminary characterisation of low-density endosomes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties